UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043130
Receipt number R000049239
Scientific Title Potential mechanisms and its microRNA interactions of platelet reductions in patients with sepsis-induced coagulopathy (Prospective obserbational study)
Date of disclosure of the study information 2021/01/25
Last modified on 2024/02/05 19:18:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Sepsis and Platelet microRNA

Acronym

Sepsis and Platelet microRNA

Scientific Title

Potential mechanisms and its microRNA interactions of platelet reductions in patients with sepsis-induced coagulopathy (Prospective obserbational study)

Scientific Title:Acronym

Role of platelet microRNA in the pathogenesis of sepis

Region

Japan


Condition

Condition

Sepsis

Classification by specialty

Anesthesiology Emergency medicine

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Elucidating the mechanisms of platelet reduction in sepsis and the role of platelet-derived microRNA in this process

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To evaluate the differences in platelet messenger RNA and microRNA expression between patients with sepsis, distinguishing those with and without platelet reduction, and comparing them to non-sepsis patients.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with and without sepsis

Key exclusion criteria

Patiets with antithrombic therapy

Target sample size

115


Research contact person

Name of lead principal investigator

1st name Yasufumi
Middle name
Last name Nakajima

Organization

Kansai Medical University

Division name

Department of Anesthesiology

Zip code

5731191

Address

Hirakatashi

TEL

09082118435

Email

nakajiya@hirakata.kmu.ac.jp


Public contact

Name of contact person

1st name Yasufumi
Middle name
Last name Nakajima

Organization

Kansai Medical University

Division name

Department of Anesthesiology

Zip code

5890014

Address

Hirakatashi

TEL

0723660221

Homepage URL


Email

nakajima@med.kindai.ac.jp


Sponsor or person

Institute

Ministry of Education, Culture, Sports, Science and Technology

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kansai Medical University

Address

Hirakatashi

Tel

0728040101

Email

kmuinfo@hirakata.kmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 05 Month 21 Day

Date of IRB

2019 Year 06 Month 21 Day

Anticipated trial start date

2019 Year 06 Month 22 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective Obserbational Study


Management information

Registered date

2021 Year 01 Month 25 Day

Last modified on

2024 Year 02 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049239


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name